Xavier Matias-Guiu Guia
Grau: Doctor/a
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Grups
Publicacions
-
Rofes P; González S; Navarro M; Moreno-Cabrera JM; Solanes A; Darder E; Carrasco E; Iglesias S; Salinas M; Gómez C; Velasco À; Tuset N; Varela M; Llort G; Ramon Y Cajal T; Grau È; Dueñas N; de la Ossa Merlano N; Matías-Guiu X; Rivera B; Balmaña J; Pineda M; Brunet J; Capellá G; Del Valle J; Lázaro C
Paired Somatic-Germline Testing of 15 Polyposis and Colorectal Cancer-Predisposing Genes Highlights the Role of APC Mosaicism in de Novo Familial Adenomatous Polyposis.
Journal Of Molecular Diagnostics 23 1452-1459. .
-
Soria X; Vilardell F; Maiques Ó; Barceló C; Sisó P; de la Rosa I; Velasco A; Cuevas D; Santacana M; Gatius S; Matías-Guiu X; Rodrigo A; Macià A; Martí RM
BRAF(V600E)
Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics
Cancers 13 -. .
-
Eritja N; Navaridas R; Ruiz-Mitjana A; Vidal-Sabanés M; Egea J; Encinas M; Matias-Guiu X; Dolcet X
Endometrial PTEN Deficiency Leads to SMAD2/3 Nuclear Translocation
Cancers 13 -. .
-
Manning-Geist BL; Gatius S; Liu Y; Gil M; Da Cruz Paula A; Tuset N; Abu-Rustum NR; Aghajanian C; Weigelt B; Matias-Guiu X
Diagnosis and management of an endometrial cancer patient with Cowden syndrome.
GYNECOLOGIC ONCOLOGY 163 14-21. .
-
Guerra E; Matias-Guiu X
Relevance of pathologic features in risk stratification for early-stage endometrial cancer.
Journal of Gynecologic Oncology 32 -. .
-
Concin N; Matias-Guiu X; Creutzberg CL; ESGO-ESTRO-ESP Endometrial Carcinoma Guideline Working Group
Response to: Are we confident treating pT1a G1 lymphovascular space invasion-negative patients (with myometrial invasion) with chemoradiotherapy on the basis of p53abn?
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 31 947-947. .
-
Gil-Moreno A; Alonso-Alconada L; Díaz-Feijoo B; Domingo S; Vilar A; Hernández A; Gilabert J; Llueca A; Torné A; de Santiago J; Carbonell-Socias M; Lago V; Arias E; Sampayo V; Siegrist J; Chipirliu A; Sánchez-Iglesias JL; Pérez-Benavente A; Padilla-Iserte P; Santacana M; Matias-Guiu X; Abal M; Lopez-Lopez R
M-TRAP: Safety and performance of metastatic tumor cell trap device in advanced ovarian cancer patients.
GYNECOLOGIC ONCOLOGY 161 681-686. .
-
Buza N; Euscher ED; Matias-Guiu X; McHenry A; Oliva E; Ordulu Z; Parra-Herran C; Rottmann D; Turner BM; Wong S; Hui P
Reproducibility of scoring criteria for HER2 immunohistochemistry in endometrial serous carcinoma: a multi-institutional interobserver agreement study.
Modern Pathology 34 1194-1202. .
-
Devis-Jauregui L; Eritja N; Davis ML; Matias-Guiu X; Llobet-Navàs D
Autophagy in the physiological endometrium and cancer.
Autophagy 17 1-19. .
-
Velasco A; Tokat F; Bonde J; Trim N; Bauer E; Meeney A; de Leng W; Chong G; Dalstein V; Kis LL; Lorentzen JA; Tomic S; Thwaites K; Putzová M; Birnbaum A; Qazi R; Primmer V; Dockhorn-Dworniczak B; Hernández-Losa J; Soares FA; Gertler AA; Kalman M; Wong C; Carraro DM; Sousa AC; Reis RM; Fox SB; Fassan M; Brevet M; Merkelbach-Bruse S; Colling R; Soilleux E; Teo RYW; D'Haene N; Nolet S; Ristimäki A; Väisänen T; Chapusot C; Soruri A; Unger T; Wecgowiec J; Biscuola M; Frattini M; Long A; Campregher PV; Matias-Guiu X
Multi-center real-world comparison of the fully automated Idylla™ microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed paraffin-embedded tissue of colorectal cancer.
VIRCHOWS ARCHIV 478 851-863. .
-
Moukarzel LA; Da Cruz Paula A; Ferrando L; Hoang T; Sebastiao APM; Pareja F; Park KJ; Jungbluth AA; Capella G; Pineda M; Levin JD; Abu-Rustum NR; Ellenson LH; Bel AV; Reis-Filho JS; Matias-Guiu X; Cadoo K; Stadler ZK; Weigelt B
Clonal relationship and directionality of progression of synchronous endometrial and ovarian carcinomas in patients with DNA mismatch repair-deficiency associated syndromes.
Modern Pathology 34 994-1007. .
-
Mendaza, S; Fernandez-Irigoyen, J; Santamaria, E; Arozarena, I; Guerrero-Setas, D; Zudaire, T; Guarch, R; Vidal, A; Salas, JS; Matias-Guiu, X; Ausin, K; Gil, C; Hernandez-Alcoceba, R; Martin-Sanchez, E
Understanding the Molecular Mechanism of miR-877-3p Could Provide Potential Biomarkers and Therapeutic Targets in Squamous Cell Carcinoma of the Cervix
Cancers 13 -. .
Projectes
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
